FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
208081NDABIOFRONTERA001AMELUZGEL;TOPICAL10%AMINOLEVULINIC ACID HYDROCHLORIDE2016-05-10PrescriptionYes
050769NDABIOFRONTERA001AKTIPAKGEL;TOPICAL5%;3%BENZOYL PEROXIDE; ERYTHROMYCIN2000-11-27DiscontinuedNo